New drug is gamechanger in psoriasis treatment

A novel drug almost entirely cleared moderate to severe psoriasis in over 60% of the patients who took part in two phase three clinical trials of a new drug.

Obstetrics & gynaecology

Pregnant after the first dose of COVID-19 vaccine—now what?

Two of the COVID-19 vaccines currently authorized for emergency use by the U.S. Food and Drug Administration require two doses to reach the full level of protection. But what happens if a woman finds out she's pregnant after ...


First cell-based gene therapy approved for multiple myeloma

Abecma (idecabtagene vicleucel), a chimeric antigen receptor (CAR) T-cell therapy, was approved by the U.S. Food and Drug Administration for the treatment of multiple myeloma, the agency announced Saturday.


Trial finds no overall effect of statins on muscle pain

A trial published by The BMJ today finds no overall effect of statins on the frequency or severity of muscle symptoms compared with placebo in people who had previously reported severe muscle symptoms when taking statins.


Sequence African genomes for Africa and the world: scientist

A $4.5 billion initiative to sequence the genomes of three million Africans would not only benefit a continent long neglected in gene-based healthcare, but advance understanding of genetic disease worldwide, the project leader ...

page 1 from 6